Cargando…

Changes in blood eosinophilia during omalizumab therapy as a predictor of asthma exacerbation

INTRODUCTION: Omalizumab is a monoclonal anti-immunoglobulin E antibody developed for the treatment of severe allergic asthma. The number of exacerbations used as a parameter of omalizumab therapy efficacy may be insufficient in many cases due to a relatively short time to first evaluation (16 weeks...

Descripción completa

Detalles Bibliográficos
Autores principales:	Skiepko, Roman, Ziętkowski, Ziemowit, Łukaszyk, Mateusz, Budny, Wojciech, Skiepko, Urszula, Milewski, Robert, Bodzenta-Łukaszyk, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2014
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221351/ https://www.ncbi.nlm.nih.gov/pubmed/25395927 http://dx.doi.org/10.5114/pdia.2014.40973

Ejemplares similares

Omalizumab treatment in brittle asthma
por: Skiepko, Roman, et al.
Publicado: (2014)

Efficacy of ciclesonide in the treatment of patients with asthma exacerbation
por: Zietkowski, Ziemowit, et al.
Publicado: (2019)

Endothelin-1 in exhaled breath condensate of allergic asthma patients with exercise-induced bronchoconstriction
por: Zietkowski, Ziemowit, et al.
Publicado: (2007)

Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients.
por: Zietkowski, Ziemowit, et al.
Publicado: (2010)

GDF-15, iron, and inflammation in early chronic kidney disease among elderly patients
por: Lukaszyk, Ewelina, et al.
Publicado: (2016)

Zonulin, inflammation and iron status in patients with early stages of chronic kidney disease
por: Lukaszyk, Ewelina, et al.
Publicado: (2017)

Fibroblast growth factor 23, iron and inflammation – are they related in early stages of chronic kidney disease?
por: Lukaszyk, Ewelina, et al.
Publicado: (2016)

Fluticasone/formoterol combination therapy is as effective as fluticasone/salmeterol in the treatment of asthma, but has a more rapid onset of action: an open-label, randomized study
por: Bodzenta-Lukaszyk, Anna, et al.
Publicado: (2011)

Diagnosis of solitary extramedullary plasmacytoma located in the nasopharynx in a patient with acquired angioedema
por: Czaban, Marcin, et al.
Publicado: (2018)

Omalizumab in patients with severe asthma and persistent sputum eosinophilia
por: Mukherjee, Manali, et al.
Publicado: (2019)

Polish Society of Allergology statement on the diagnosis and treatment of severe, difficult-to-control bronchial asthma
por: Kupczyk, Maciej, et al.
Publicado: (2019)

Effectiveness of omalizumab in an asthmatic patient with severe airway and blood eosinophilia
por: Kupryś-Lipińska, Izabela, et al.
Publicado: (2015)

Role of Th17 cells and IL-17, IL-23 cytokines in pathogenesis of autoimmune thyroid disease in children
por: Bossowski, Artur, et al.
Publicado: (2013)

Endothelial progenitor cell levels in juvenile idiopathic arthritis patients; effects of anti-inflammatory therapies
por: Rusak, Malgorzata, et al.
Publicado: (2015)

Development of Asthmatic Response upon Bronchial Allergen Challenge Is Associated with Dynamic Changes of Interleukin-10-Producing and Interleukin-10-Responding CD4+ T Cells
por: Moniuszko, Marcin, et al.
Publicado: (2014)

Delayed diagnosis of human immunodeficiency virus infection in a patient with non-specific neurological symptoms and pancytopenia: a case report
por: Moniuszko, Marcin, et al.
Publicado: (2014)

Can eosinophilia and neutrophil–lymphocyte ratio predict hospitalization in asthma exacerbation?
por: Esmaeilzadeh, Hossein, et al.
Publicado: (2021)

Effects of Deoxynivalenol and Zearalenone on the Histology and Ultrastructure of Pig Liver
por: Skiepko, Natalia, et al.
Publicado: (2020)

Caspase-1 deficiency reduces eosinophilia and interleukin-33 in an asthma exacerbation model
por: Menzel, Mandy, et al.
Publicado: (2017)

Severe asthma and the omalizumab option
por: Miller, Christopher WT, et al.
Publicado: (2008)

Decreased CD127 Expression on CD4+ T-Cells and Elevated Frequencies of CD4+CD25+CD127− T-Cells in Children with Long-Lasting Type 1 Diabetes
por: Moniuszko, Marcin, et al.
Publicado: (2013)

Omalizumab for Severe Asthma: Beyond Allergic Asthma
por: Loureiro, C. C., et al.
Publicado: (2018)

4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
por: Snelder, S. M., et al.
Publicado: (2017)

Asthmatic adult with marked blood eosinophilia: is it truly asthma?
por: Tan, Shera, et al.
Publicado: (2018)

Omalizumab for severe allergic asthma: a life changing drug?
por: Mesonjesi, Eris, et al.
Publicado: (2015)

Omalizumab: Clinical Use for the Management of Asthma
por: Thomson, Neil C., et al.
Publicado: (2012)

Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality
por: Oshagbemi, Olorunfemi A., et al.
Publicado: (2018)

Monitoring Injuries Associated with Mandated Children’s Products in Australia: What Can the Data Tell Us?
por: Vallmuur, Kirsten, et al.
Publicado: (2018)

Asthma and exercise-induced respiratory disorders in athletes. The position paper of the Polish Society of Allergology and Polish Society of Sports Medicine
por: Gawlik, Radoslaw, et al.
Publicado: (2019)

Predictors of reversible airway obstruction with omalizumab in severe asthma: a real-life study
por: Solidoro, Paolo, et al.
Publicado: (2019)

Infection, eosinophilia and childhood asthma
por: Kim, Chang-Keun, et al.
Publicado: (2012)

The Diagnostic Value of Inflammatory Markers (CRP, IL6, CRP/IL6, CRP/L, LCR) for Assessing the Severity of COVID-19 Symptoms Based on the MEWS and Predicting the Risk of Mortality
por: Wolszczak-Biedrzycka, Blanka, et al.
Publicado: (2023)

Cognitive Functioning of Geriatric Patients: Is Hypovitaminosis D the Next Marker of Cognitive Dysfunction and Dementia?
por: Łukaszyk, Ewelina, et al.
Publicado: (2018)

Identification of Mortality Risks in the Advancement of Old Age: Application of Proportional Hazard Models Based on the Stepwise Variable Selection and the Bayesian Model Averaging Approach
por: Łukaszyk, Ewelina, et al.
Publicado: (2021)

Characteristics of Induced-Sputum Inflammatory Phenotypes in Adults with Asthma: Predictors of Bronchial Eosinophilia
por: Crespo-Lessmann, Astrid, et al.
Publicado: (2023)

Update on optimal use of omalizumab in management of asthma
por: Pelaia, Girolamo, et al.
Publicado: (2011)

279 Near-Fatal Asthma Treated with Omalizumab
por: Contreras Contreras, Elvia Angelica, et al.
Publicado: (2012)

A review of omalizumab for the management of severe asthma
por: Lin, Ching-Hsiung, et al.
Publicado: (2016)

Biomarkers of delayed graft function as a form of acute kidney injury in kidney transplantation
por: Malyszko, Jolanta, et al.
Publicado: (2015)

Neutrophil/Lymphocyte Ratio (NLR) and Lymphocyte/Monocyte Ratio (LMR) – Risk of Death Inflammatory Biomarkers in Patients with COVID-19
por: Dymicka-Piekarska, Violetta, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_59cs5h0j51fmhpj56pudqhhqol